BMT from an HLA-identical sibling donor is an effective treatment. Patients undergoing transplantation in the chronic phase have a 50 to 80% chance of long-term disHypermetaphase FISH (HMF), a molecular cytogenetic procedure combining the long term mitotic arrest of ease-free survival. [4][5][6] Much of the benefit of allogeneic BMT is mediated by an immune graft-versus-leukemia bone marrow cultures with detection of a specific chromosomal rearrangement by fluorescence in situ effect. The most direct evidence of this effect is the finding that infusion of donor lymphocytes reinduces complete hybridization (FISH), has recently been shown to be effective in determining the frequency of Philadelphia remission in approximately 70% of patients relapsing post-BMT. Donor lymphocyte infusions are most effective when chromosome positive (Ph+) cells in the bone marrow of chronic myelogenous leukemia (CML) patients given early in the course of relapse. 7,8 It is important to detect minimal residual disease and undergoing treatment. By combining the probe for the Ph chromosome with one for the detection of the X early relapse for effective therapeutic intervention. Standard G-band cytogenetic analysis provides information on chromosome, we used HMF to monitor the presence of malignant cells within the emerging host cell population only a relatively small number of cells (Ͻ25 metaphases) making the detection of a low frequency of Ph+ cells probin the marrow of a CML patient that had undergone sex-mismatched allogeneic bone marrow transplanlematic. More sensitive PCR-based molecular assays for BCR/ABL rearrangement frequently detect the presence of tation. In successive studies, we detected 0.5% and 1.75% Ph+ cells, respectively, confirmed by Western Ph+ cells, but the clinical significance of this finding is unclear since patients may remain in prolonged complete blot analysis for p210 protein. These readings occurred concordantly with a repopulation of host-derived dipremission despite persistently positive results. 9 We have combined fluorescence in situ hybridization (FISH) with loid female cells. Standard G-band cytogenetic analyses did not detect any Ph+ cells at these time points. Interlong-term colcemid exposure of bone marrow cultures (called hypermetaphase FISH or HMF) and shown it to be vention with donor lymphocyte infusion reinduced complete remission. This experience indicates that HMF is effective in monitoring the presence of specific chromosomal entities present in low frequency in leukemia patients useful to identify low levels of repopulation by Ph+ cells in the marrow post-BMT at a stage when intervention undergoing treatment.
Summary:
BMT from an HLA-identical sibling donor is an effective treatment. Patients undergoing transplantation in the chronic phase have a 50 to 80% chance of long-term disHypermetaphase FISH (HMF), a molecular cytogenetic procedure combining the long term mitotic arrest of ease-free survival. [4] [5] [6] Much of the benefit of allogeneic BMT is mediated by an immune graft-versus-leukemia bone marrow cultures with detection of a specific chromosomal rearrangement by fluorescence in situ effect. The most direct evidence of this effect is the finding that infusion of donor lymphocytes reinduces complete hybridization (FISH), has recently been shown to be effective in determining the frequency of Philadelphia remission in approximately 70% of patients relapsing post-BMT. Donor lymphocyte infusions are most effective when chromosome positive (Ph+) cells in the bone marrow of chronic myelogenous leukemia (CML) patients given early in the course of relapse. 7, 8 It is important to detect minimal residual disease and undergoing treatment. By combining the probe for the Ph chromosome with one for the detection of the X early relapse for effective therapeutic intervention. Standard G-band cytogenetic analysis provides information on chromosome, we used HMF to monitor the presence of malignant cells within the emerging host cell population only a relatively small number of cells (Ͻ25 metaphases) making the detection of a low frequency of Ph+ cells probin the marrow of a CML patient that had undergone sex-mismatched allogeneic bone marrow transplanlematic. More sensitive PCR-based molecular assays for BCR/ABL rearrangement frequently detect the presence of tation. In successive studies, we detected 0.5% and 1.75% Ph+ cells, respectively, confirmed by Western Ph+ cells, but the clinical significance of this finding is unclear since patients may remain in prolonged complete blot analysis for p210 protein. These readings occurred concordantly with a repopulation of host-derived dipremission despite persistently positive results. 9 We have combined fluorescence in situ hybridization (FISH) with loid female cells. Standard G-band cytogenetic analyses did not detect any Ph+ cells at these time points. Interlong-term colcemid exposure of bone marrow cultures (called hypermetaphase FISH or HMF) and shown it to be vention with donor lymphocyte infusion reinduced complete remission. This experience indicates that HMF is effective in monitoring the presence of specific chromosomal entities present in low frequency in leukemia patients useful to identify low levels of repopulation by Ph+ cells in the marrow post-BMT at a stage when intervention undergoing treatment. ously twice a day for 14 days). After four courses, she achieved a complete hematologic remission. Cytogenetic analysis revealed a reduction of Ph+ (33%). However, in Western blotting September 1991 interferon-␣ was discontinued because of P210 assays: The ECL Western blotting detection system toxicity (ie an episode of psychosis and severe depression).
was used to probe for BCR-ABL protein according to the During maintenance therapy with hydroxyurea a reversion manufacturer's protocol (Amersham, Arlington Heights, IL, to 100% Ph+ chromosome occurred. She remained in the USA). Filters were preblocked by washing with 10% nonchronic phase of CML. In June 1992, 28 months after diagfat milk (NFM) in Tris-buffered saline-Tween 20 (TBS-T) nosis, she received a T cell-depleted allogeneic BMT from buffer (20 mmol/l Tris base, 137 mmol/l NaCl, 0.0038 n an unrelated male donor. The patient and the unrelated HCl) for 2 h and then incubated with 1:15 000 to 20 000 donor were phenotypically matched in their HLA-A, B, C, dilution of 8E9 in 5% NGM TBS-T buffer overnight at DR and DQ antigens. The conditioning regimen was thioroom temperature. The filters were then incubated with a tepa 10 mg/kg, cyclophosphamide 120 mg, and total body 1:3 000 to 3 500 dilution of horseradish peroxidase (HRP)-radiation (12 Gy in four daily fractions). Graft-versus-host labeled sheep anti-mouse IgG (Amersham, cat. no. NA disease prophylaxis consisted of anti-CD5 ricin A chain 9310) for 2 h. The filters were mixed with ECL reagents immunotoxin (Xomazyme-CD5 plus), cyclosporine and and exposed to X-ray film for 1 to 10 min. Where indicated, methylprednisolone. She achieved trilineage engraftment the intensities of P210 BCR-ABL, the lower molecular and hematopoietic reconstitution. On day 24 post-BMT, the weight BCR-ABL proteins, and P145 ABL within appropripatient was discharged and received cyclosporine until 6 ate autoradiograms were scanned with a densitometer months post-transplant.
(Personal Densitometer; Molecular Dynamics, Sunnyvale, Bone marrow examination on day 30 post-BMT revealed CA, USA).
12 trilineage engraftment with a normal differential. Her posttransplant course was uneventful. She did not have infec-
HMF (hypermetaphase FISH):
After 24 h culture of bone tious complications or graft-versus-host disease. Bone marmarrow aspirates followed by the addition of colcemid 1 row aspiration on day 100 was normal (cellularity 25%) g/ml and culture for an additional 24 h for the hypermetawith exclusively donor cells by cytogenetics. Similar findphase preparation, 10 cells were fixed in acid-alcohol and ings were found in bone marrow studies at 6 months and dropped on slides by procedures standard in this laboratory. 1 year post-transplant. In May 1994 (2 years post-BMT)
For FISH detection of the Ph chromosome the E6B probe, physical examination was within normal limits and WBC from 5 Mb of human DNA spanning the breakpoint on was 5.4 × 10 9 /l (61 polymorphs, 5 bands, 26 lymphocytes, chromosome 9q34 involved in the Ph translocation, was 7 monocytes, 1 eosinophil), platelet: 137 × 10 9 /l and, hemolabeled with biotin for visualization with fluorescein. globin 11.6 g%. Bone marrow aspiration again revealed Digoxigenin-labeled alpha satellite DNA probe (Oncor, normal trilineage hematopoiesis. Cytogenetic studies by Gaithersburg, MD, USA) for chromosome X, locus DXZ1 FISH revealed repopulation by normal diploid female cells, was used for FISH identification (visualization with 28 out of 400 (7%) metaphases, indicating recrudescence rhodamine) of donor cell vs recipient cells. 13 Two-color of host-derived hematopoiesis which became increasingly detection for each of the probes, fluorescent microscopy dominant over time. In September 1994, the patient's RBC and photography as carried out in this laboratory were carshowed a mixed field agglutination reaction with anti-A and ried out as has been reported. 21 Criteria for evaluating Ph+ anti-B (patient's pre-BMT blood type was B+ and the donor and Ph− cells were as published, 10 two chromosome regions blood type was A−). The majority of RBC were hostof equal green fluorescence indicating Ph− cells and three derived blood group B. Molecular studies and immunologic chromosome regions (one clearly less robust than the other reconstitution are summarized in Table 1. two) for Ph+ cells. Donor cells (male) were identified as having only one red fluorescent chromosomal region while female recipient cells had two such regions (see Figure 1 where a host derived, Ph+ cell is shown as an example).
Materials and methods
Blood and marrow samples were obtained after written ever, one out of 30 metaphases was recipient-derived 46XX presence of A and B red cells in the patient's blood in an estimated ratio of 20-30 host to 70-80%, donor respectively.
Hypermetaphase FISH
Data on 2-year allogeneic BMT revealed that 7% of the cells (28 metaphases of 400 analyzed) were recipientderived. However, no Ph+ cells were present. Four months later, the percentage of recipient-derived cells increased to 68% (272) metaphases out of 400 metaphases analyzed) and in two recipient cells, the Ph+ chromosome was identified (0.5%) ( Table 1) . A typical cell is seen in Figure 1 . By 2.5 years after BMT, 82% of dividing marrow cells were recipient-derived and seven Ph+ metaphases were identified (2.1% of the recipient cells). The increased frequency of Ph+ cells in the marrow at this time point was statistically significant compared to that seen at 2 years post-BMT. Western blot analysis revealed a trace positive result at these two time points. Southern blotting was persistently germline post-transplant ( 2 = 7.02, P Ͻ 0.008). The presence of increasing Ph+ cells with autologous repopulation of hematopoiesis prompted treatment with a donor lymphocyte infusion depleted of CD8-positive cells on 22 December 1994. 15 The patient responded to this intervention and subsequently no Ph+ cells were identified up to 12 months following the infusion (Table 1) .
Discussion
Figure 1 Two-color FISH using EGB probe (green) which detects the Allogeneic BMT is an effective therapy for the treatment 9q34 region of human chromosome 9 and DXZ1 probe (red) which detects of CML. With transplants from a matched sibling donor, the centromere on the X chromosome. The cell shown is clearly female 50-80% chronic phase patients achieve long-term disease-(two X chromosomes) and Ph+ (a third chromosomal element with reduced green fluorescence). free survival. Unrelated donor transplants are also curative but are associated with a greater risk of graft-versus-host disease (GVHD) and graft failure.
14,16 Patients who relapse after allogeneic blood marrow transplantation can achieve (3%) by conventional cytogenetics. At 1 year post-transplant, a sample for cytogenetics revealed insufficient metadurable remission after donor lymphocyte infusion to induce a graft-versus-leukemia effect. Donor lymphocyte phases (one metaphase was donor origin and one metaphase was recipient-derived). In May 1994, 2 years post-transinfusion is most effective to induce remission and least likely to be complicated by marrow aplasia when adminisplant, recipient-derived cells increased to 24% with random structural and numerical changes (Table 1) , probably tered early in the course of relapse. 15 This makes early detection of residual or recurrent CML important for resulting from the irradiation exposure during the conditioning regimen. Thirty months post-transplant only patient management. Following allogeneic BMT, many patients have small recipient cells were identified (most with chromosomal abnormalities) but no Ph+ cells were detected.
numbers of residual Ph chromosome positive cells that can be identified by cytogenetic or molecular analyses. In some cases, Ph+ cells are only transiently present, but in others RBC blood group their numbers increase leading to overt relapse. 17, 18 Monitoring the course of patients with Ph+ CML by routine cytoThe results of testing for residual Ph+ cells and for chimerism are summarized in Table 1 . The patient's original blood genetic analysis is suboptimal due to inability to study a sufficient number of cells. Hypermetaphase FISH (HMF) group was B-Rh-positive before and the donor A-Rh-positive. Thirty-three days post-transplantation the patient's red analysis of a large number of metaphases by in situ hybridization markedly improves detection of residual disblood cells typed both A and B positive, indicating the presence of both donor and host-derived erythrocytes. Three ease and allows quantitative assessment in the frequency of Ph+ cells. 10 Several hundred metaphases per sample can months later the patient's blood group had completely converted to the donor's type blood group (A-negative) and she be analyzed within 1 h. In this case HMF on one 2-year post-BMT sample revealed 93% (302/400) male cells and was transfusion independent. After 28 months and without intercurrent transfusion, a mixed field reaction was 7% (28/400) female cells, with no Ph+ positive cells. However, in September 1994, HMF revealed an increment of observed when tested with anti-A and anti-B, indicating the female cells (recipient) (272/400) (68%) including, 0.5% an increase or decrease in this population over time. This information may be useful for prognosis, treatment (2/400) of Ph+ cells. The confidence interval in the measurement of Ph+ cells was reduced from 10-15% by planning and allowing early intervention for persistent or recurrent leukemia. cytogenetics to less than Ϯ0.5% by HMF. This is an unusual case with repopulation of predominantly hostderived diploid cells with a small fraction of Ph+ cells. Donor lymphocyte infusion (DLI) produced remission. This References suggests that host Ph+ cells were more sensitive to the effect of DLI or that a leukemia specific antigen was tar- ively detecting a low frequency of Ph+ cells, and assessing
